Innobiochips specializes in developing advanced multiplex immunoassays, which are tests that can measure multiple biomarkers simultaneously to provide sensitive and reproducible diagnostics. The company's core technology, SirYus, enables the creation of fully integrated, user-friendly, and cost-competitive diagnostic tools. These tools are particularly useful in the fields of infectious diseases, blood screening, and transplantation. By combining several biomarkers in a single assay, Innobiochips' technology allows for faster and more accurate diagnosis, which is crucial for timely medical intervention.

Innobiochips serves a diverse range of clients, including hospitals, diagnostic laboratories, and research institutions. The company operates in the healthcare and biotechnology markets, focusing on providing solutions that improve diagnostic accuracy and efficiency. Its business model revolves around the development, manufacturing, and sale of diagnostic kits and systems. Revenue is generated through the direct sale of these products, as well as through partnerships and licensing agreements with other healthcare and biotech companies.

The company is committed to innovation and continuously works on enhancing its technology to meet the evolving needs of the healthcare industry. Innobiochips' solutions are designed to be scalable and adaptable, making them suitable for a wide range of applications, from routine diagnostics to specialized medical research.

Keywords: multiplex immunoassays, biomarkers, diagnostics, infectious diseases, blood screening, transplantation, SirYus technology, healthcare, biotechnology, medical innovation.